NUAK1 and Miyoshi myopathy: 5′ adenosine monophosphate (AMP)-activated protein kinase–related kinase 5 (ARK5) is a known transcriptional target of large MAFs in MM [9] and a potential therapeutic target for improving outcomes in patients with MM.